Frontlight ResearchEarly access
Trial site
Bari
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia2 trials
- Multiple sclerosis2 trials
- Myeloproliferative neoplasms2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Epilepsy1 trial
- Gastric and oesophageal cancer1 trial
- Hidradenitis suppurativa1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Thalassaemia1 trial
- Phase
- Phase 36 trials
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals11 trials
Running trials
Recruiting
Active, not recruiting
ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Terminated
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026